| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.09 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |